CollPlant Biotechnologies (CLGN) EPS (Basic) (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted EPS (Basic) of -$0.23 for Q1 2026, up 91.35% on a QoQ basis from -$2.62 in Q4 2025, and down 57.49% year-over-year from -$0.53 in Q1 2025.
CollPlant Biotechnologies (CLGN) EPS (Basic) (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.23 for Q1 2026.
- Quarterly EPS (Basic) fell 57.49% year-over-year to -$0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.58 (down 3.48% YoY) and the FY2025 annual result came in at -$3.27, up 4.57% from the prior year.
- EPS (Basic) was -$0.23 for Q1 2026 at CollPlant Biotechnologies, up from -$2.62 in the prior quarter.
- Across five years, EPS (Basic) topped out at $11131.4 in Q2 2023 and bottomed at -$5655.4 in Q2 2022.
- A 5-year average of $321.54 and a median of -$0.28 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 296.83% — and 2025, when it tumbled 138.06%.
- CollPlant Biotechnologies' EPS (Basic) stood at -$2.46 in 2022, then climbed by 13.14% to -$2.14 in 2023, then fell by 9.26% to -$2.33 in 2024, then fell by 12.26% to -$2.62 in 2025, then soared by 91.35% to -$0.23 in 2026.
- Business Quant data shows CLGN's EPS (Basic) at -$0.23 in Q1 2026, -$2.62 in Q4 2025, and -$0.28 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 0.00 |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | 0.00 |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 1.55 |
| 10 | CollPlant Biotechnologies | 4.50 Mn | 4.50 Mn | -243,000.00 | -0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -0.23 |
| Dec 31, 2025 | -2.62 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | 0.27 |
| Mar 30, 2025 | -0.14 |
| Dec 31, 2024 | -2.33 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 0.38 |
| Dec 31, 2023 | -2.14 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | 11,131.37 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | -2.46 |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | -5,655.41 |
| Mar 31, 2022 | 0.35 |
| Dec 31, 2021 | -22.83 |
| Sep 30, 2021 | 6.85 |
| Jun 30, 2021 | -3,925.00 |